Oxidative stress occurs as a result of an imbalance between the production of reactive oxygen species (ROS) and the cell's capacity to neutralize them through its intrinsic antioxidant defenses. Neurons are particularly susceptible to oxidative damage because of their high levels of ROS production (through respiration and metabolism) and relatively low levels of certain antioxidant enzymes, particularly catalase 1, 2 . Oxidative damage accumulates in normal aging and is involved in the pathogenesis of several neurodegenerative diseases, as well as acute cerebrovascular disorders 1, 2 .
Regulation of cellular oxidation-reduction reaction balance depends on the activity of antioxidant systems. Important among these are the thiol-reducing systems that are based on thioredoxin and glutathione, which are important reducers of many oxidative stressors such as peroxides 2, 3 . The thioredoxin system protects cells against H 2 O 2 -induced cell death, and its inhibition promotes oxidative stress 3 . Thioredoxin-overexpressing mice show less oxidative brain damage following ischemia and live longer 3 .
The thioredoxin system detoxifies peroxides by transferring reducing equivalents from NADPH to peroxides via thioredoxin reductase, thioredoxin and Prxs. Prxs are a family of cytoprotective, antioxidative proteins [4] [5] [6] . The 2-Cys Prxs are the predominant Prx subfamily, comprising Prx I-IV 7 . These Prxs contain a peroxidatic cysteine residue, which is oxidized by peroxides to cysteine sulfenic acid (-SOH). Cysteine sulfenic acid then forms a disulfide bond with the resolving cysteine, which is in turn reduced by thioredoxin 7 . Sometimes, under increased oxidative stress, peroxiredoxin sulfenic acid is further oxidized by peroxide to sulfinic (-SO 2 H) or sulfonic (-SO 3 H) acid, causing inactivation of peroxidase activity 8 . Peroxiredoxin sulfinic/sulfonic acid, Prx-SO 2/3 H, is not a substrate for the resolving cysteine and cannot be reduced by thioredoxin. As such, Prx overoxidation to Prx-SO 2/3 H was thought to be irreversible. Recently, it has been found that Prx-SO 2/3 H can be reduced back to the catalytically active thiol form by two ATPdependent reductases, sulfiredoxin 8 and sestrin 2 (ref. 9) . It is unknown whether neurons have the capacity to reduce overoxidized Prxs.
There is a growing awareness of the neuroprotective effects of synaptic activity 10 . In vitro and in vivo studies have revealed that part of this activity-dependent neuroprotection is mediated by synaptic NMDAR activity 11, 12 . NMDAR blockade can trigger widespread neuronal death, an effect that peaks in the first postnatal week in rats 13 . Newborn neurons of the adult dentate gyrus also require NMDAR activity to survive 14 . Where NMDAR blockade does not kill neurons, it can make neurons vulnerable to trauma 15 .
Despite the importance of neuronal antioxidant defenses, little is known about whether they are subject to dynamic regulation or are a fixed function of neuronal type and age. This is an important question, as any regulation could influence biological aging or progression of neurodegeneration. Here, we studied the influence of synaptic activity on the capacity of neurons to deal with oxidative stress. We found that synaptic activity exerts a profoundly positive effect, mediated by a coordinated program of gene expression changes that is centered on the thioredoxin-Prx system.
RESULTS

Synaptic NMDAR activity boosts antioxidant defenses
Postnatal day 6 (P6) mice were injected with MK-801, an uncompetitive antagonist of the NMDAR, which induced widespread TUNELpositive cell death in the cortex (Fig. 1a) , as has been reported for rat brains 13 . We next determined whether this death was associated with oxidative stress. Following injection of MK-801 or vehicle, cortical proteins were extracted and subjected to two-dimensional electrophoresis, and protein carbonyl levels (a marker of oxidative damage) were assayed. MK-801 triggered the carbonylation of many cortical proteins (Fig. 1b,c) . Thus, suppression of physiological NMDAR activity promotes oxidative damage in the P6-7 cortex. We then investigated the influence of synaptic NMDAR activity on rat cortical neuronal vulnerability to an oxidative insult (H 2 O 2 ) in vitro. Blockade of spontaneous firing with tetrodotoxin (TTX) exacerbated H 2 O 2 -induced neuronal death (Fig. 1d) , as did blockade of spontaneous NMDAR activity by MK-801 (Fig. 1d) .
It is probable that most spontaneous NMDAR activity is synaptic, induced by spontaneous firing, and not extrasynaptic (the culture media was free of glutamate). To investigate this, we carried out an analysis of open-channel blockade of NMDARs by MK-801 in currentclamped neurons, which revealed a reduction of 43 ± 5% by 5 min that then plateaued ( Supplementary Fig. 1a online). This current loss was blocked by TTX ( Supplementary Fig. 1b , compare activity block with TTX), demonstrating that spontaneous NMDAR activity is dependent on action potential firing and is therefore probably synaptic. To confirm this, we blocked synaptic NMDARs using an established method of holding cells under voltage clamp in the presence of MK-801, TTX and zero Mg 2+ (ref. 16 ). Spontaneous release of quanta of glutamate activates synaptic NMDARs, which are then blocked by MK-801. As with the previous 'activity block' protocol (Supplementary Fig. 1a) , the current that is antagonized using this 'quantal 600,000 500,000 400,000 300,000 TUNEL-positive cells mm -3 Intraperitoneal injection Derivitized carbonyl spot intensity 200,000 100,000
Veh. (b,c) Analysis of carbonyl content of two-dimensionally separated proteins from the cortices of P7 mice subjected to intraperitoneal injection of MK-801. Blotted two-dimensional electrophoresis gels were stained with silver to reveal protein spots (right; MW, molecular weight; pI, isoelectric point block' of synaptic NMDARs plateaus ( Supplementary Fig. 1c-e) . The amount of current blocked using both protocols was similar ( Supplementary Fig. 1b) . Furthermore, we carried out the quantal block protocol after the activity block protocol and found no further loss of current ( Supplementary Fig. 1b) . Thus, spontaneous NMDAR activity is predominantly synaptic and dependent on action potential firing. Consistent with this, MK-801 combined with TTX did not increase the amount of cell death beyond that induced by either drug alone ( Supplementary Fig. 1f ), suggesting that TTX and MK-801 act via a common pathway that stops spontaneous synaptic NMDAR activity. As expected, MK-801 does not affect underlying firing activity (excitatory postsynaptic current frequency was unchanged, Supplementary Fig. 1g) ; it is the activation of NMDARs promoted by that underlying activity that is important to the antioxidative effect. We then used the established method of network disinhibition to enhance synaptic activity by applying the GABA A receptor antagonist bicuculline and the K + channel antagonist 4-aminopyridine (which enhances burst frequency and is hereafter referred to as BiC/4-AP; ref. 17) . BiC/4-AP treatment reduced H 2 O 2 -induced neuronal death (Fig. 1d) , an effect blocked by TTX ( Supplementary Fig. 1h ) and also by MK-801 (Fig. 1d) . BiC/4-AP treatment triggers activation of synaptic, but not extrasynaptic, NMDARs 17 . Therefore, the effect of MK-801 in inhibiting the BiC/4-AP-induced neuroprotection is likely to be the result of synaptic NMDAR blockade, as has been demonstrated in recent publications 17, 18 . It should be noted, though, that there may have been some extrasynaptic NMDAR activity as a result of dying cells releasing glutamate during H 2 O 2 exposure, which would also be blocked by MK-801. Later experiments, however, firmly implicated synaptic NMDARs as being responsible for the neuroprotective effect that was observed. As for other potential routes of activitydependent postsynaptic Ca 2+ influx, we saw that blockade of L-type voltage-gated calcium channels (VGCCs) with nifedipine had a small effect on neuroprotection compared with MK-801 ( Supplementary  Fig. 1i ), whereas blockade of N-type VGCCs with o-conotoxin GVIA had no effect ( Supplementary Fig. 1j ). Blockade of P/Q-type VGCCs with o-agatoxin IVA abolished BiC/4-AP-induced firing (data not shown), consistent with a role for these channels in presynaptic neurotransmitter release.
We corroborated our observations regarding the neuroprotective and antioxidative effects of synaptic NMDAR activity using an alternative measure of cell viability: cellular ATP levels (Fig. 1e) . Also, an episode of BiC/4-AP-induced synaptic NMDAR activity that was terminated before the addition of H 2 O 2 was neuroprotective (Fig. 1f) , indicating that long-lasting transcriptional events may be involved. We hypothesized that synaptic activity promotes the reduction and neutralization of cellular ROS following H 2 O 2 exposure. We used two fluorogenic ROS probes (2¢,7¢-dichlorodihydrofluorescein diacetate and dihydrorhodamine 123) to detect H 2 O 2 -induced ROS accumulation (Fig. 1g,h ). MK-801-treated neurons contained the highest levels of fluorescent (oxidized) forms of the probes when challenged with H 2 O 2 , whereas BiC/4-AP-treated neurons showed the least. Thus, H 2 O 2 -induced ROS accumulation is prevented by synaptic activity. H 2 O 2 -induced death in this model was apoptotic; it was prevented by the pan-caspase inhibitor qVD-Oph ( Supplementary  Fig. 1k ). Furthermore, H 2 O 2 treatment triggered increased activity of both the initiator caspase 9 and effector caspases 3 and 7, which was reversed by BiC/4-AP treatment ( Supplementary Fig. 1l ).
Overwhelming of the thioredoxin system by oxidative trauma Of the 2-Cys Prxs, mammalian neurons predominantly express PrxII, III and IV 19 . Consistent with this, a pan-2-Cys Prx antibody detected three bands on a western blot of protein extracts from rat cortical neurons ( Supplementary Fig. 2a online) . To identify the bands, we overexpressed PrxII, III and IV in turn (in rat cortical neurons) and found enrichment of the bottom, middle and upper endogenous bands, respectively ( Supplementary Fig. 2a ), consistent with their theoretical molecular weights. The existence of overoxidized Prx-SO 2/3 H indicates that the thioredoxin-Prx system is overwhelmed. Western blot analysis using a Prx-SO 2/3 H-specific antibody revealed that H 2 O 2 caused Prx overoxidation in control and MK-801-treated neurons, whereas BiC/4-APtreated neurons showed far less overoxidation (Fig. 2a) . MK-801 decreased the effect of BiC/4-AP ( Supplementary Fig. 2b ). These differences were not the result of BiC/4-AP-induced expression of core components of the thioredoxin-Prx system; the levels of thioredoxin, thioredoxin reductase and 2-Cys Prxs were unchanged by BiC/ 4-AP or MK-801 (Fig. 2b,c) . To find an alternative explanation, we carried out microarray expression analysis on neurons experiencing different levels of synaptic NMDAR activity. We searched for genes that were regulated in opposite directions by enhancing or suppressing synaptic NMDAR activity in vitro (BiC/4-AP versus MK-801 treatment) and were similarly regulated by NMDAR blockade in vivo. We used mouse arrays, as they offer better annotation, and mouse cortical neurons showed similar activity-dependent resistance to oxidative stress (data not shown).
Pro-oxidative Txnip is suppressed by synaptic activity Seven genes were induced by BiC/4-AP treatment (in a MK-801-sensitive manner) that were also suppressed by MK-801 in vitro and in vivo (Supplementary Table 1 online). One gene showed negative regulation by synaptic NMDAR activity: Txnip (thioredoxin-interacting protein), which binds thioredoxin, inhibits its activity and promotes vulnerability to oxidative stress 3, 20 , and which we prioritized for further study. We confirmed that Txnip regulation was NMDAR dependent by qRT-PCR in mouse (data not shown) and rat cortical neurons ( Fig. 2d) and by western blot (Fig. 2e) . A time course revealed that Txnip expression was dynamically regulated: both rapidly suppressed by activity and quickly upregulated following activity blockade with TTX ( Supplementary Fig. 2c ). A combination of MK-801 and TTX did not induce Txnip more than either drug did alone ( Supplementary  Fig. 2d ), consistent with the idea that TTX acts by preventing spontaneous synaptic NMDAR activity. Coimmunoprecipitation studies revealed that Txnip was bound to thioredoxin in MK-801-treated neurons (high Txnip levels; Fig. 2f ), which would be expected to inhibit thioredoxin activity. We measured thioredoxin enzyme activity in cell extracts taken under low-detergent conditions that were designed to preserve Txnip-thioredoxin interactions. Enzyme activity in our cultures was almost entirely neuronal: glial cells contributed only 1-2.5% of thioredoxin activity (Supplementary Methods online). Consistent with an inhibitory effect of Txnip, we observed lower levels of thioredoxin activity in extracts from MK-801-treated neurons than in extracts from BiC/4-AP-treated neurons (Fig. 2g) , despite equivalent thioredoxin protein levels at 24 and 48 h (Fig. 2b and data not shown). To determine whether Txnip renders neurons vulnerable to oxidative stress, we overexpressed it in synaptically active neurons with an enhanced green fluorescent protein (eGFP) marker to track neuronal fate. More than 99% of eGFP-expressing cells were NeuN-positive, and less than 1% were GFAP-positive (data not shown). Expression of Txnip did not alter BiC/4-AP-induced bursting ( Supplementary  Fig. 3a online) . By monitoring the neurons before and after H 2 O 2 treatment, we found that Txnip expression reduced the antioxidative effects of synaptic activity (Fig. 3a) . Consistent with its known function, thioredoxin overexpression was neuroprotective against H 2 O 2 insult (Fig. 3a) . We corroborated the effect of Txnip using a different method of monitoring the viability of transfected neurons: coexpression of a constitutively active luciferase expression construct (Fig. 3b) . Thus, Txnip influences neuronal antioxidant defenses.
Cortical neuronal death induced by NMDAR blockade is developmentally regulated; at P0 none is observed, but cell-death is widespread by P7 (refs. 13,21) . We found that the coupling of NMDAR blockade to Txnip upregulation in vivo is similarly regulated. At P0, MK-801 did not induce an increase in Txnip, in contrast with its effects at P7 (Fig. 3c) , suggesting that Txnip may contribute to cell death at P7. The absence of an effect at P0 could be a result of lower NMDAR expression at this stage. We investigated whether TXNIP mRNA expression varies with age in humans and found To determine whether suppression of Txnip expression is neuroprotective, we investigated the effect of siRNA-mediated knockdown of Txnip. Validation of Txnip-directed siRNA was hampered by the absence of an antibody that detects endogenous neuronal Txnip by immunohistochemistry and by the fact that siRNA transfection efficiency at this developmental stage is too low to analyze knockdown of endogenous protein by western blot. Because Txnip protein is sufficiently unstable that suppression of transcription is reflected at the protein level after 24 h (Fig. 2e) , we can reasonably assume that effective siRNA is able to knockdown endogenous protein levels in a similar time frame. We expressed rat Txnip in neurons and found that transfection of two different Txnip siRNAs (rTxnip siRNAs 1 and 2), but not control siRNA, blocked Txnip expression at 24 h (Fig. 3e) . Neither of the rat Txnip siRNAs impaired expression of transfected human Txnip (Supplementary Fig. 3c ), which contains two and four nucleotide differences (in central regions) from rTxnip siRNAs 1 and 2, respectively. We found that Txnip siRNA did not protect H 2 O 2 -exposed unstimulated neurons (Fig. 3f) , indicating, not surprisingly, that multiple transcriptional changes are necessary to mimic the antioxidative effect of synaptic NMDAR activity.
Induction of Prx-SO 2/3 H-reducing genes Sesn2 and Srxn1
To determine whether overoxidized Prxs could be reduced in neurons, we applied a brief, high (200 mM) dose of H 2 O 2 to induce Prx overoxidation and looked for recovery after H 2 O 2 washout. We focused on PrxII, the major neuronal cytosolic Prx 19 . Both unstimulated and MK-801-treated neurons showed no reduction in Prx-SO 2/3 H 16 h after washout (Fig. 4a) . In contrast, we observed a large reduction in postwashout Prx-SO 2/3 H levels in BiC/4-AP-treated neurons (Fig. 4a) . Thus, the degree of synaptic activity experienced can determine whether Prx overoxidation is reversible, which may affect the efficacy of H 2 O 2 detoxification by the thioredoxin-Prx system. Fig. 4b,c) , offering an explanation for the activity-dependent enhancement of Prx-SO 2/3 Hreducing capacity (Fig. 4a) . We hypothesized that upregulation of Sesn2 and Srxn1 may cooperate with the activity-dependent downregulation of Txnip in promoting resistance to oxidative insults. Overexpression of Sesn2 and Srxn1 in a cell-line (HEK293) that is amenable to high-efficiency transfection revealed that, following H 2 O 2 treatment, cells expressing both Sesn2/Srxn1 had less Prx-SO 2/3 H than control cells ( Supplementary Fig. 4 online) , which is consistent with previous studies 9, 22, 23 . We then mimicked the three activitydependent events described above by transfecting expression vectors for Sesn2 and Srxn1, as well as Txnip siRNA. We observed a reduction in cell death following H 2 O 2 insult (Fig. 4d) .
We next carried out experiments using siRNAs targeted against Sesn2 and Srxn1. Activity-dependent induction of Sesn2 expression was visualized by immunofluorescence, and two siRNAs targeted against Sesn2 (siRNA 1 and 2) knocked down Sesn2 expression (Fig. 4e) . Validation of Srxn1-directed siRNAs was hampered by the absence of an antibody that detects endogenous neuronal Srxn1 by immunohistochemistry. Instead, we overexpressed Srxn1 with an eGFP marker and analyzed the effectiveness of the siRNA in preventing Srxn1 expression, eventually finding two that knocked down Srxn1, siRNA 3 and 4 (Fig. 4f) .
We paired the siRNAs (1 with 3 and 2 with 4) to test the effect of combined knockdown of Sesn2 and Srxn1. BiC/4-AP-induced protection was diminished in neurons transfected with either pair of siRNAs (Fig. 4g) . We also tested the effect of these siRNA pairs on long-lasting protection afforded by a prior episode of synaptic activity (Fig. 1f) and found a similar effect (Fig. 4h) . (Fig. 5a) . FOXOs undergo nuclear export in response to Akt-dependent phosphorylation 24 , and Akt is activated by synaptic NMDAR activity via phosphatidylinositol-3-kinase (PI3K) 18 . Consistent with a role for FOXOs in Txnip regulation, inhibition of PI3K with LY294002 elevated basal Txnip mRNA and protein expression and blocked activity-dependent suppression of Txnip (Fig. 5b) . We next cloned the Txnip promoter upstream of a luciferase reporter (Txnip-Luc) and introduced a 
mutation into the putative FOXO binding site (Txnip(mut)-Luc).
Txnip-Luc showed the expected activity-dependent suppression (Fig. 5c) , whereas Txnip(mut)-Luc showed lower basal activity and did not undergo activity-dependent suppression (Fig. 5c) . Overexpression of the major neuronal FOXOs, FOXO1 or FOXO3a, enhanced Txnip-Luc promoter activity, but failed to activate Txnip(mut)-Luc (Fig. 5d) . Therefore, Txnip contains a functional FOXO site that mediates activitydependent inactivation of the promoter. Moreover, we found that BiC/4-AP treatment triggered PI3K-dependent FOXO1 phosphorylation ( Fig. 5e ) and nuclear export (Fig. 5f ).
In contrast, MK-801 enhanced nuclear localization of FOXO1 (Fig. 5f) . A mutant FOXO that had its Akt phosphorylation sites mutated (FOXO-ADA) 25 did not undergo activity-dependent export (data not shown). Chromatin immunoprecipitation (ChIP) experiments revealed that endogenous FOXO1 associates with the Txnip promoter in MK-801-treated neurons more strongly than in BiC/4-AP-treated neurons ( Fig. 5g,h) . As a negative control, ChIP with a phospho-FOXO1 antibody failed to immunoprecipitate the Txnip promoter (Fig. 5h) . Consistent with their intermediate nature with regard to Txnip expression and FOXO localization, the untreated neurons showed variable FOXO promoter occupancy: sometimes resembling MK-801-treated neurons and sometimes resembling BiC/4-AP-treated neurons (Fig. 5h) . These data support a model whereby synaptic activity turns off Txnip transcription by inducing the PI3K-Akt pathway and triggering FOXO phosphorylation, dissociation from the Txnip promoter and export from the nucleus.
Sesn2 is a C/EBP target gene, Srxn1 is an AP-1 target gene We created a Sesn2 luciferase reporter (Sesn2-Luc), which was activated by BiC/4-AP-induced NMDAR activity ( Supplementary Fig. 5a online). Deletion analysis identified the activity-inducible region as being between -494 and -107 relative to the transcription start site (Fig. 6a) . Further deletions revealed that inducibility was conferred by two regions, -378 to -249 and -249 to -107 (data not shown). In silico analysis revealed a potential binding site for the transcription factor CCAAT enhancer binding protein (C/EBP) in each of these regions. Moreover, expression of an interfering mutant of C/EBP, DC/EBP 26 , inhibited activity-dependent induction of Sesn2-Luc (Fig. 6b) . Mutation of the proximal putative C/EBP site impaired activity-dependent induction of Sesn2-Luc (Fig. 6c) , whereas mutation of both sites abolished induction (Fig. 6c) . Therefore, we conclude that induction of Sesn2 by synaptic activity is mediated largely by C/EBP. Transcription of the Cebpb gene (but not Cebpa) was induced by BiC/4-AP stimulation (Fig. 6d and data not shown) , raising the possibility that this new expression may be important for Sesn2 induction. Consistent with this, Sesn2 is not an immediate early gene; it was not induced at 1 h (Supplementary Fig. 5b) , and its induction at 4 h was severely inhibited by the protein synthesis inhibitor cycloheximide (Supplementary Fig. 5b ). Cebpb is a CREBregulated immediate early gene 27 ; the induction of which is not inhibited by cycloheximide (Supplementary Fig. 5c ). The rapid induction of Cebpb at 1 h contrasts with the slower induction of Sesn2, consistent with the predominantly delayed-response nature of Sesn2 induction. (Fig. 1a) .
We created a Srxn1-luciferase reporter that was activated by BiC/4-AP-induced NMDAR activity (Supplementary Fig. 5a ). Deletion analysis identified the activity-inducible region between -645 and -234 relative to the translation start site (Fig. 6e) . Analysis of this region revealed two putative AP-1 sites (TGAGTCA). Ca 2+ signaling is known to activate AP-1 family members, which was confirmed by our observation that BiC/4-AP stimulation activates a heterologous AP-1 reporter 6.1 ± 0.61 fold (n ¼ 4) compared with unstimulated neurons. Overexpression of AP-1 (c-fos and c-jun) strongly induced activity of the Srxn1 reporter, which was impaired when either of the putative AP-1 sites were mutated and was abolished in the double mutant (Fig. 6f) . Moreover, mutation of either site reduced activity-dependent induction of the Srxn1 reporter construct and the double mutation abolished induction (Fig. 6g) . Thus, Srxn1 is activated via AP-1 sites in its promoter.
Extrasynaptic NMDARs fail to boost antioxidant defenses Trans-synaptic activation of synaptic NMDARs is anti-apoptotic; however, chronic activation of all (synaptic and extrasynaptic) NMDARs by bath application of glutamate or NMDA is not 17 . Moreover, synaptic versus bath activation of NMDARs promote very different transcriptional responses 28 . We tested whether trans-synaptic activation of synaptic NMDARs is critical for NMDAR-dependent antioxidative effects or whether bath application of glutamate will suffice. We bath-applied a range of glutamate doses to rat cortical neurons (up to the toxicity threshold, 20 mM) in the presence of TTX to ensure that there was no preferential activation of synaptic NMDARs, as can occur 29 . Stimulations were compared with control (TTX only).
We first analyzed bath application glutamate signaling to Akt, FOXO export and Txnip suppression. Sustained glutamate exposure triggered only transient Akt activation (Fig. 7a) and weak FOXO export (Fig. 7b) . Suppression of Txnip expression was poor compared with that induced by BiC/4-AP stimulation (Fig. 7c) . Also, in contrast to BiC/4-AP stimulation, no dose of bath glutamate induced either Sesn2 or Srxn1 or Sesn2's activator, Cebpb (Fig. 7d-f) , which is consistent with previous observations 28 . Consistent with this, glutamate did not promote the reduction of overoxidized Prxs (Fig. 7g,h ), nor did it protect against H 2 O 2 -induced death (Fig. 7i) . Thus, the strong antioxidative effect of NMDAR signaling is restricted to the trans-synaptic activation of synaptic NMDARs and is not a preconditioning-type effect in response to subtoxic glutamate exposure.
We next investigated whether these differences are due to the results of NR2 subunit differences between synaptic and extrasynaptic NMDARs, as NR2A-containing NMDARs may be enriched at synaptic locations 30 and signal for neuroprotection more effectively than NR2B-containing NMDARs 31 . Both whole-cell NMDAR currents and extrasynaptic NMDAR currents (analyzed by blocking synaptic NMDARs with the quantal block protocol, Supplementary Fig. 1c ) were blocked by 70% by the NR2B antagonist ifenprodil (Fig. 8a) . Ifenprodil does not completely block responses even when mediated exclusively by NR2B-containing NMDARs (around 80% is achieved 32 ). Thus, synaptic and extrasynaptic NMDARs are overwhelmingly and equally NR2B-dominated, a probable consequence of the relatively early developmental stage under study.
We hypothesized that both the harmful and protective consequences of NMDAR activation in these neurons would be inhibited by NR2B antagonists. Both ifenprodil and Ro 25-6981 protected neurons from cell death that was induced by a toxic dose of NMDA (50 mM; Fig. 8b ). NR2B antagonists also impaired protective signaling by trans-synaptic activation of synaptic NMDARs; ifenprodil and Ro 25-6981 exacerbated neuronal death by H 2 O 2 (Fig. 8c) , caused an upregulation of Txnip (Fig. 8d) , reduced BiC/4-AP-induced protection against H 2 O 2 -induced death (Fig. 8e) and reduced Sesn2 and Srxn1 activation (Fig. 8f) . Thus, the differences in the effect of synaptic stimulation versus bath application of agonist are probably not the results of large, clear-cut differences in NR2 subunit composition at synaptic and extrasynaptic sites. However, we cannot rule out a role for NR2A-containing NMDARs at the synapse, as this would require analyses of NR2A-null neurons.
Memantine is an open-channel blocker with a fast off-rate. Its uncompetitive nature results in an effective blockade of chronic NMDAR activity caused by bath-applied glutamate 33 . However, because of its fast off-rate and voltage-dependent binding properties, memantine does not substantially interfere with normal synaptic NMDAR activity by accumulating in the channel 33 . In the context of this study, memantine appears to be suitable for sparing the antioxidative effects of trans-synaptic activation of synaptic NMDARs, while blocking chronic activation of NMDARs by low-level glutamate that does not enhance antioxidant defenses (Fig. 7i) .
Memantine (at 5 or 10 mM) blocked NMDAR-dependent neuronal death that is induced by 50 mM NMDA (Fig. 8g) . However, it did not interfere with trans-synaptic NMDAR-dependent activation of antioxidant defenses; unlike MK-801, memantine did not exacerbate H 2 O 2 -induced death (Fig. 8h) , promote nuclear localization of FOXOs (Fig. 8i) or Txnip expression (Fig. 8j) , and did not interfere with synaptic activity-dependent signaling leading to Sesn2 and Srxn1 activation (Fig. 8k,l) , Txnip suppression (Fig. 8m) or activitydependent neuroprotection against H 2 O 2 (Fig. 8n) . We also assessed the effects of memantine administration in vivo at a dose (20 mg per kg of body weight) that has consistently been shown to be therapeutically active in protecting against ischemic insults 34 and is known to result in brain concentrations similar to those used in our in vitro experiments 35 . Unlike MK-801, memantine injection did not cause neuronal apoptosis in the P7 cortex; we did not observe death by either TUNELstaining (Fig. 8o) or Fluorojade staining, which labels degenerating neurons irrespective of the mechanism of death (data not shown). The differential effects of MK-801 and memantine emphasize that transsynaptic stimulation of synaptic NMDARs is important for boosting antioxidant defenses and that blockade of synaptic NMDARs boosts vulnerability to oxidative stress in vitro and in vivo.
Overoxidation of Prxs by ischemia and reperfusion
We wanted to determine whether the thioredoxin system becomes overwhelmed in an in vivo model of neuronal death. We chose ischemia Figure 9 An ischemic episode, followed by reperfusion, induces overoxidation of Prxs. Western analysis of Prx-SO 2/3 H formation in homogenate from the MCA territory (cortex and striatum) of mice subjected to 60 min MCAO followed by 3 h reperfusion, compared with the equivalent region from shamoperated mice. Bottom, western blot of the six ischemic and five control samples. Top, analysis of the western blot shown on bottom.
and reperfusion as a model, as it is associated with an acute wave of oxidative damage that affects a substantial population of neurons and is implicated in the pathological process 1 . We subjected adult mice to 60 min of middle cerebral artery (MCA) occlusion and examined extracts from their cortical regions at 4 h postreperfusion, which is before development of the infarct. Increased Prx-SO 2/3 H formation in the MCA territory (cortex and striatum) following ischemia and reperfusion was evident when compared with equivalent samples from the sham-operated individuals (Fig. 9) . The profile of overoxidation was subtly different from that of in vitro H 2 O 2 treatment; PrxIII was overoxidized to a greater extent by ischemia and reperfusion than by H 2 O 2 treatment. Thus, Prx-SO 2/3 H formation does occur in vivo in response to brain insult, indicating that the thioredoxin-Prx system is overwhelmed. This lends added relevance to our findings concerning the regulation of genes whose products can influence this system.
DISCUSSION
We have demonstrated that neuronal antioxidative defenses are subject to activity-dependent enhancement that is mediated by synaptic NMDAR signaling. A coordinated program of gene expression changes with a net antioxidative effect underlies this enhancement. The changes described center on the thioredoxin-Prx system and involve hitherto uncharacterized activity-regulated genes.
Txnip promotes oxidative stress and cell death Txnip interacts with the reduced form of thioredoxin, inhibits its biochemical activity and sensitizes a variety of cell types to H 2 O 2 -induced death 3, 20 . Txnip is implicated in the pathogenesis of diabetes: it is upregulated in the vasculature and pancreatic b cells of diabetic rats and is induced by hyperglycemia in both systems, promoting oxidative stress 20, 36 . Txnip is also involved in oncology and has been proposed to suppress tumor cell growth and metastasis, and reduced levels have been observed in a variety of cancers 3 . The influence of Txnip on neuronal vulnerability to oxidative stress is consistent with its role as a pro-oxidative gene in non-neuronal systems.
Studies on transcriptional control by synaptic Ca 2+ signals focus almost exclusively on upregulated genes. Results here concerning the regulation of Txnip expression demonstrate that gene inactivation must also be considered. Our findings that Txnip is regulated by FOXOs adds to our knowledge of FOXO-regulated pro-death genes, which have so far focused mainly on Bim and Fasl 24, 37 .
Prxs are cytoprotective antioxidant enzymes Prxs are a family of thiol-based antioxidants with cytoprotective effects in the face of oxidative insults. PrxII protects cortical neurons against Ab toxicity 38 and oxygen-glucose deprivation 39 . Interfering with PrxII expression renders neuroblastoma cells vulnerable to oxidative stress 5 and cortical neurons vulnerable to 1-methyl-4-phenylpyridinium (MPP + ) 6 . PrxIII protects hippocampal neurons against excitotoxicity 4 .
Low reported catalytic rates for Prxs have led to the suggestion that Prxs are not able to compete with catalase or glutathione peroxidases for cellular peroxide, despite evidence of the antioxidative properties of Prxs. This apparent paradox was due to an underestimation of peroxidase rates of mammalian PrxII, which was a result of indirectly calculating the peroxidase rates by measuring NADPH oxidation rates, which in turn measure regeneration by the thioredoxin system. When peroxide levels are high, it is clear that the thioredoxin system cannot keep up. In fact, when rates of mammalian Prx were measured directly 40 , they were found to be 100-fold greater than previously thought, similar to rates recently found in PrxI and II from S. cerevisiae 41 . Because Prxs are relatively abundant, they are likely to be important antioxidants in mammalian in vivo systems.
Thus, molecular events that render Prxs inactive in vivo in pathological scenarios may contribute to disease progression. We observed Prx-inactivating Prx-SO 2/3 H formation following cerebral ischemia in vivo (Fig. 9 ), but this is not the only way by which Prxs can be inhibited. The enzymatic activity of PrxII can be impaired by cyclindependent kinase 5-mediated phosphorylation 6 and by nitrosylation 42 , both of which occur in Parkinson's disease 6, 42 .
Reactivation of Prx-SO 2/3 H by sulfiredoxin and sestrin 2 Sulfiredoxin was characterized first in yeast 43 and then in mammalian cells 8 , and it acts by catalyzing the ATP-dependent formation of a sulfinic acid phosphoric ester on Prx 8 , which is then reduced by thiol equivalents such as thioredoxin. The ATP-dependent mechanism by which Sesn2 reduces Prx-SO 2/3 H is incompletely understood 9 . It was not previously known that neurons had the capacity to reduce inactive Prx-SO 2/3 H, and our findings show that active neurons have a far greater capacity for this than inactive neurons and are associated with high levels of Srxn1 and Sesn2. This is the first time that Prx-SO 2/3 H-reducing activity has been found to be signal dependent. The widespread expression of these genes raises the question of whether the Prx-SO 2/3 H reduction process is inducible by signaling in vivo. For example, ischemic preconditioning is associated with activation of AP-1 (ref. 44) , which could therefore result in upregulation of Srxn1 expression and reduce the Prx-SO 2/3 H formation that occurs following ischemia (Fig. 9) .
Activity-dependent regulation of antioxidant defenses
It is not clear why synaptic activity, acting via Ca 2+ signaling, should act to boost antioxidant defenses. One possibility is that this occurs to protect against increased ROS generation; electrical activity and its downstream physiological consequences are expensive, energetically and metabolically. Because ROS are generated as byproducts of respiration and many other metabolic pathways, the regulation of antioxidant defenses may be a homeostatic mechanism to ensure the correct oxidation-reduction reaction balance in the neuron. However, our findings show that the effects of synaptic activity go beyond protecting against increased endogenous ROS production, as it renders neurons resistant to an exogenously applied insult.
One implication resulting from our work is that a neuron's lifelong pattern of activity may influence its accumulation of oxidative damage and, ultimately, its longevity during aging, or affect the progression of pathological processes associated with oxidative damage, such as Alzheimer's or Parkinson's disease. This raises the question of whether altered patterns of neuronal activity in vivo can alter neuronal antioxidative capacity in response to changes in behavior or environment. Rodent environmental enrichment is neuroprotective and modulates the onset and severity of models of Alzheimer's disease and Huntington's disease, whereas a cognitively stimulating lifestyle in humans may reduce the risk of Alzheimer's disease and Parkinson's disease 45, 46 . The possibility that environmental enrichment may, through altered or increased patterns of neuronal activity, result in increased antioxidant defenses in those brain regions that are more intensively used is intriguing. We found that only 5 min of BiC/4-AP-induced burst activity significantly induced Srxn1 expression and induced downregulation of Txnip (by 40 and 60%, respectively (P ¼ 0.0006 and P ¼ 0.01); Supplementary Fig. 6a,b online) , raising the possibility that modest episodes of elevated activity in vivo may trigger substantial changes.
NMDAR blockade can trigger widespread neuronal death-an effect that peaks in the first few postnatal weeks in rats. NMDAR blockade does not kill adult neurons outright 13 . Consistent with this, carbonyl assay of cortical proteins from MK-801-injected adult mice (Supplementary Fig. 7 online) revealed no significant increases in carbonylation of any proteins (in sharp contrast to the P7 cortex; Fig. 1b) , although there was a trend toward an increase in carbonylation in several spots. NMDAR blockade in the adult CNS can exacerbate death in response to metabolic inhibition or traumatic brain injury 11, 15 . The borderline effects of MK-801 in the adult cortex with regard to oxidative stress ( Supplementary Fig. 7 ) may translate to more substantial increases when the brain is subject to an additional trauma and may contribute to the increased neuronal death that is observed 11, 15 .
The growing understanding of the neuroprotective effects of physiological synaptic NMDAR activity, coupled with its established role in synaptic plasticity, suggests that global NMDAR antagonism may not be appropriate as an anti-excitotoxic or anti-apoptotic therapeutic strategy 12, 47 . Memantine is a NMDAR antagonist that is approved for use on individuals with Alzheimer's disease, and, unlike conventional antagonists, it has properties that are suited to sparing trans-synaptic activation of synaptic NMDARs while blocking continuous low-level NMDAR activation by chronic glutamate exposure 33 . This enhancement of physiological signal over pathological noise is thought to improve plastic processes at the synapse and to prevent apoptosis caused by chronic low-level activation of NMDARs 33 . In our hands, memantine was able to prevent NMDAR-dependent excitotoxic cell death while not inhibiting the antioxidative effects of trans-synaptic activation of synaptic NMDARs. These findings are consistent with memantine's clinically tolerated mechanism of action 33 .
The aging human brain is associated with an accumulation of oxidative damage 2 . Elevated levels of Txnip expression in the aging human cortex (Fig. 3d) may be a consequence of lowered levels of activity and could conceivably influence vulnerability to oxidative stress. The situation is exacerbated in individuals with Alzheimer's disease, where Txnip levels are further elevated 48 , as are the levels of FOXO1 and FOXO3 mRNA 48 , activators of Txnip (Fig. 5) . Whether any of these changes in expression are contributing factors to pathogenesis or are merely an epiphenomenon is not clear. Nor is it clear whether expression of Srxn1 or Sesn2 is altered in neurodegenerative diseases. An understanding of the signals and genes that control neuronal antioxidant defenses may point the way to therapeutic strategies aimed at slowing neurodegeneration in a variety of disorders associated with oxidative damage.
METHODS
Neuronal cultures, stimulation and the induction of oxidative stress. Cortical rat neurons were cultured as described 18 from embryonic day 21 (E21) rats or E17 mouse pups in Neurobasal-A medium and B27 (Invitrogen). Stimulations and transfections (Lipofectamine 2000, Invitrogen) were carried out at 8-10 days in vitro after transferring neurons into trophically deprived medium 18 . Action potential bursting was induced by treatment with 50 mM bicuculline and 250 mM 4-aminopyridine (Sigma) to enhance burst frequency. Stimulations were initiated 12 h before the application of an oxidative insult. Neurons were fixed after a further 24 h and subjected to DAPI staining, and cell death was quantified by counting (blind) the number of apoptotic nuclei as a percentage of the total. For details of the analysis of H 2 O 2 -induced ROS accumulation and caspase activity, see the Supplementary Methods online.
Electrophysiological recording and analysis. Currents were recorded (at 21 ± 2 1C) using an Axopatch-1C amplifier (Molecular Devices). Data were digitized and analyzed using WinEDR v6.1 software (J. Dempster, University of Strathclyde). Neurons were voltage-clamped at -70 mV, and recordings were rejected if the holding current was more than -100 pA or if the series resistance drifted by 420% of its initial value (o35 MO). See the Supplementary Methods for details of solutions, drugs, and the activity block and quantal block protocols.
Gene expression analysis by qPCR and microarray. For qPCR, cDNA was synthesized from 1-3 mg RNA (extracted using Qiagen RNeasy kit) using the Stratascript QPCR cDNA Synthesis kit and qPCR was carried out in an Mx3000P QPCR System (Stratagene) using Brilliant SYBR Green QPCR Master Mix. For detailed protocols and primer sequences, see the Supplementary Methods. For microarray-based expression analysis, total RNA was quality confirmed on RNA 6000 Nano Chips in the Agilent 2100 Bioanalyzer (Agilent). Purified biotinylated target cRNA was produced (see Supplementary Methods) and hybridized to Mouse Genome 430A Plus 2.0 microarrays (Affymetrix). After hybridization, the arrays were washed and scanned (Genechip Scanner 3000, Affymetrix). Expression was calculated using the robust multiarray average algorithm implemented in the Bioconductor (http://www.bioconductor. org) extensions to the R statistical programming environment.
In vivo procedures. In vivo MK-801 and memantine administration, TUNEL histology, and protein carbonyl assays of extracted proteins were all carried out using established techniques. In vivo focal cerebral ischemia was performed on adult male C57BL/6J mice under an appropriate Home Office License. See the Supplementary Methods for details of all in vivo procedures.
Other experimental procedures and materials. Neuronal transfections, following the fate of transfected cells, luciferase assays, immunofluorescence staining, western blotting, ChIP, coimmunoprecipitation and thioredoxin enzyme assays all involved standard protocols (see the Supplementary Methods for these and information on plasmids, siRNA and antibodies).
Note: Supplementary information is available on the Nature Neuroscience website.
